323 related articles for article (PubMed ID: 27365080)
1. Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Hillyer GC; Chen L; Hershman DL
Breast Cancer Res Treat; 2016 Jul; 158(2):373-84. PubMed ID: 27365080
[TBL] [Abstract][Full Text] [Related]
2. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
[TBL] [Abstract][Full Text] [Related]
3. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
[TBL] [Abstract][Full Text] [Related]
4. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
Huang NS; Si J; Yang BL; Quan CL; Chen JJ; Wu J
Cancer Med; 2018 Jan; 7(1):56-63. PubMed ID: 29271113
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
[TBL] [Abstract][Full Text] [Related]
6. [A single-center retrospective study on axillary evaluation in 1 557 breast ductal carcinoma in situ patients between 2006 and 2016].
Si J; Quan CL; Mo M; Guo R; Su YH; Yang BL; Chen JJ; Shao ZM; Wu J
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):681-685. PubMed ID: 31474060
[No Abstract] [Full Text] [Related]
7. Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
Killelea BK; Long JB; Dang W; Mougalian SS; Evans SB; Gross CP; Wang SY
Ann Surg Oncol; 2018 Jun; 25(6):1521-1529. PubMed ID: 29516364
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ with microinvasion.
Adamovich TL; Simmons RM
Am J Surg; 2003 Aug; 186(2):112-6. PubMed ID: 12885600
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
10. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
11. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection.
Golshan M; Martin WJ; Dowlatshahi K
Am Surg; 2003 Mar; 69(3):209-11; discussion 212. PubMed ID: 12678476
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA
Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
[TBL] [Abstract][Full Text] [Related]
15. Modern Trends in the Surgical Management of Paget's Disease.
Wong SM; Freedman RA; Stamell E; Sagara Y; Brock JE; Desantis SD; Golshan M
Ann Surg Oncol; 2015 Oct; 22(10):3308-16. PubMed ID: 26202552
[TBL] [Abstract][Full Text] [Related]
16. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis].
Zhu SJ; Chen XS; Wu JY; Huang O; He JR; Zhu L; Chen WG; Li YF; Fei XC; Shen KW
Zhonghua Wai Ke Za Zhi; 2017 Feb; 55(2):114-119. PubMed ID: 28162210
[No Abstract] [Full Text] [Related]
17. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
[TBL] [Abstract][Full Text] [Related]
19. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
20. The incidence and predictor of lymph node metastasis for patients with T1mi breast cancer who underwent axillary dissection and breast irradiation: an institutional analysis.
Lee JH; Suh YJ; Shim BY; Kim SH
Jpn J Clin Oncol; 2011 Oct; 41(10):1162-7. PubMed ID: 21903706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
